← Eichor
Study identifier: NCT04685356 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of the IBAIP in Preterm Infants Neurodevelopment

Condition: Premature Birth  ·  Sponsor: University Hospital, Brest

PhaseNA
Planned participants240
Who can joinAll sexes, 25 Weeks to 32 Weeks
Healthy volunteersNo

About this study

Mortality in very preterm infants has decreased significantly over the past twenty years. However, neuromotor, behavioral and cognitive development disorders are more common in these children born before 33 weeks of gestation as compared to term born infants. These neurodevelopmental disorders include difficulties with self-regulation, tone, posture or poor quality movements as well as inadequate responses to sensory simulation. Post-hospital discharge follow-up and interventionsof children born very preterm ares very heterogeneous in France. They are mainly carried out in a rehabilitation center, based on caregivers whereas IBAIP is carried out at home and family centered. Early interventions during hospitalization or after discharge appear potentially of great interest in improving the neurodevelopemental outcome of the very preterm infants. Several early interventions have been developed and evaluated in other countries. These interventions are designed to be used early in life, mainly during the first 3 years of life, and are based on brain plasticity and intense synaptogenesis during this period of life. The IBAIP (Infant Behavior Assessment and Intervention Program) was developed on the same theoretical foundations as the NIDCAP (Neonatal Individualized Development Care and Assessment Program). IBAIP consists of providing the child and his family with an intervention, at home, starting just before hospital discharge up to a 6 months corrected age. .The aim of IBAIP …

This description comes directly from the study's public registry record.

Talk to the study team

Jean-Michel ROUE, PhD  ·  2.98.22.36.67  ·  jean-michel.roue@chu-brest.fr

Always discuss trial participation with your own doctor first.

Locations (9)

CHU AngersAngers, FranceRecruiting
CHU BesançonBesançon, FranceRecruiting
CHU BrestBrest, FranceRecruiting
CHU CaenCaen, FranceRecruiting
CHU GrenobleGrenoble, FranceRecruiting
CHU NantesNantes, FranceWithdrawn
CHU RennesRennes, FranceWithdrawn
CHRU StrasbourgStrasbourg, FranceRecruiting
CHU ToursTours, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04685356